We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+12.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.51B
AUM Growth
+$44.7M
Cap. Flow
-$67.2M
Cap. Flow %
-4.44%
Top 10 Hldgs %
7.69%
Holding
917
New
264
Increased
151
Reduced
280
Closed
215

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$8.11M
2
EFX icon
Equifax
EFX
+$7.99M
3
APTV icon
Aptiv
APTV
+$7.68M
4
SEDG icon
SolarEdge
SEDG
+$7.42M
5
POOL icon
Pool Corp
POOL
+$7.29M

Sector Composition

Rank Sector Weight
1 Healthcare 25.15%
2 Technology 21.25%
3 Consumer Discretionary 17.38%
4 Industrials 11.43%
5 Financials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPZM
226
DELISTED
Epizyme, Inc
EPZM
$1.75M 0.12%
146,462
-13,654
-9% -$183K
BJRI icon
227
BJ's Restaurants
BJRI
$1.47B
$1.74M 0.12%
59,204
-25,996
-31% -$669K
RGNX icon
228
Regenxbio
RGNX
$616M
$1.74M 0.12%
63,323
+41,657
+192% +$1.36M
AQUA
229
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$1.72M 0.11%
81,001
-76,773
-49% -$1.53M
AMBA icon
230
Ambarella
AMBA
$3.04B
$1.72M 0.11%
32,930
-60,166
-65% -$2.91M
SFL icon
231
SFL Corp
SFL
$1.61B
$1.7M 0.11%
227,483
-23,717
-9% -$207K
LULU icon
232
lululemon athletica
LULU
$13.5B
$1.68M 0.11%
+5,100
New +$1.7M
NVMI
233
Nova
NVMI
$11.7B
$1.67M 0.11%
32,100
-4,900
-13% -$251K
IRWD icon
234
Ironwood Pharmaceuticals
IRWD
$586M
$1.67M 0.11%
185,517
-51,983
-22% -$517K
NTLA icon
235
Intellia Therapeutics
NTLA
$1.51B
$1.66M 0.11%
83,509
-18,634
-18% -$389K
ATRA icon
236
Atara Biotherapeutics
ATRA
$72.6M
$1.66M 0.11%
5,116
-1,020
-17% -$347K
PATK icon
237
Patrick Industries
PATK
$2.87B
$1.66M 0.11%
43,197
-10,533
-20% -$422K
ARCH
238
DELISTED
Arch Resources, Inc.
ARCH
$1.64M 0.11%
+38,600
New +$1.37M
MYGN icon
239
Myriad Genetics
MYGN
$476M
$1.64M 0.11%
+125,449
New +$1.59M
GPRO icon
240
GoPro
GPRO
$120M
$1.63M 0.11%
358,700
-51,751
-13% -$243K
GTHX
241
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.62M 0.11%
139,924
+99,005
+242% +$1.63M
LAB icon
242
Standard BioTools
LAB
$342M
$1.61M 0.11%
+217,066
New +$1.5M
ZUO
243
DELISTED
Zuora, Inc.
ZUO
$1.57M 0.1%
152,301
+85,944
+130% +$995K
MEOH icon
244
Methanex
MEOH
$4.23B
$1.55M 0.1%
63,700
-29,000
-31% -$616K
YEXT icon
245
Yext
YEXT
$573M
$1.55M 0.1%
101,944
-76,294
-43% -$1.29M
CVA
246
DELISTED
Covanta Holding Corporation
CVA
$1.53M 0.1%
197,837
+134,859
+214% +$1.24M
VCEL icon
247
Vericel Corp
VCEL
$2.38B
$1.52M 0.1%
82,307
-9,597
-10% -$159K
XNCR icon
248
Xencor
XNCR
$1.45B
$1.52M 0.1%
39,213
-4,814
-11% -$167K
EB
249
DELISTED
Eventbrite
EB
$1.52M 0.1%
139,997
-56,337
-29% -$560K
ROCC
250
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$1.52M 0.1%
154,121
+128,020
+490% +$1.36M

Similar funds

PDT Partners's Q3 2020 Portfolio in Review

As of Q3 2020, PDT Partners held 917 positions worth $1.51B, up 3% from $1.47B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

PDT Partners withdrew a net $67.2M in Q3 2020, closing 215 positions and reducing 280 holdings. Its most notable exit was Electronic Arts, an estimated $8.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in Illumina worth $7.08M.

  • PDT Partners's largest Q3 2020 buy was Illumina: 23,541 shares worth $7.08M.
  • PDT Partners added most to Pool Corp in Q3 2020, an estimated $7.29M increase.
  • PDT Partners's biggest Q3 2020 reduction was Bloom Energy, cutting an estimated $13.7M.
  • PDT Partners fully exited Electronic Arts in Q3 2020, selling an estimated $8.6M.
  • PDT Partners's ten largest holdings make up 7.7% of its $1.51B portfolio in Q3 2020.
  • PDT Partners opened 264 new positions and closed 215 in Q3 2020.
  • PDT Partners's portfolio value rose 3% quarter-over-quarter to $1.51B.

Based on PDT Partners's 13F filing for Q3 2020, filed 16 Nov 2020.